Amphastar Pharmaceuticals (AMPH) Interest & Investment Income (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Interest & Investment Income of $2.4 million for Q1 2026, up 14.89% year-over-year from $2.1 million in Q1 2025, and down 0.95% quarter-over-quarter from $2.4 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Interest & Investment Income (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Interest & Investment Income history runs 14 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 14.89% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $9.0 million (down 11.38% YoY), while the FY2025 annual figure was $8.7 million, down 18.22% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $2.4 million, down from $2.4 million in the prior quarter.
- The five-year high for Interest & Investment Income was $3.3 million in Q2 2024, with the low at $181000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $2.1 million (2025), against an average of $1.7 million.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income soared 410.5% in 2023, then tumbled 42.43% in 2025.
- Amphastar Pharmaceuticals' Interest & Investment Income stood at $580000.0 in 2022, then surged by 297.07% to $2.3 million in 2023, then fell by 0.48% to $2.3 million in 2024, then gained by 5.72% to $2.4 million in 2025, then retreated by 0.95% to $2.4 million in 2026.
- Business Quant data shows AMPH's Interest & Investment Income at $2.4 million in Q1 2026, $2.4 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 934.85 Mn | 644.73 Mn | 93.47 Mn | 2.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.29 Mn |
| Mar 31, 2026 | 2.40 Mn |
| Dec 31, 2025 | 2.42 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 1.92 Mn |
| Mar 31, 2025 | 2.09 Mn |
| Dec 31, 2024 | 2.29 Mn |
| Sep 30, 2024 | 2.43 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Mar 31, 2024 | 2.56 Mn |
| Dec 31, 2023 | 2.30 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 924,000.00 |
| Dec 31, 2022 | 580,000.00 |
| Sep 30, 2022 | 331,000.00 |
| Jun 30, 2022 | 229,000.00 |
| Mar 31, 2022 | 181,000.00 |
| Dec 31, 2021 | 157,000.00 |
| Sep 30, 2021 | 141,000.00 |